U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549607) titled 'Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting' on March 12.
Brief Summary: The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.
Study Start Date: April 01
Study Type: OBSERVATIONAL
Condition:
Primary Bilary Cirrhosis (PBC)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Leipzig
Information provided by (Responsible Party): Johannes Wiegand, University of Leipzig
Published by HT Digital Content Services with permission from Health Dai...